21 patients in limbo as talks on funding life-saving drug Respreza break down

Irish patients are set to lose access to life-saving lung disease drug Respreza.

21 patients in limbo as talks on funding life-saving drug Respreza break down
Thu, 14 Sep, 2017 - 18:14

Irish patients are set to lose access to life-saving lung disease drug Respreza.

Talks on funding Respreza have collapsed between the HSE and CSL Behring, the pharmaceutical company which makes it.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Cost of electricity: halogen bulb and twenty Euro notes Energy suppliers not making 'excessive' profits from soaring gas and electricity prices, watchdog says
Weather 'time machine' shows daily conditions for past 86 years Weather 'time machine' shows daily conditions for past 86 years
Ambulance strike will significantly impact services, HSE warns Ambulance strike will significantly impact services, HSE warns
CourtsHeathrowPlace: KinsealyPlace: north DublinPlace: USPlace: EuropePlace: IrelandPerson: Gerry FinnertyOrganisation: ResprezaOrganisation: HSEOrganisation: CSL BehringOrganisation: AATD
<p>Munster Technological University (MTU) said that it is continuing to engage with Instructure to understand the nature and extent of any potential impact on the university community. File picture: Larry Cummins</p>

Irish universities continue to probe extent of cyberattack on Canvas learning platform

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited